Bacterin Reports Further Expansion of Sales Force

Bacterin InternationalHoldings, Inc. (NYSE: BONE), a leader in the development of bone graftmaterial and bioactive coatings for medical applications, today announcedthree senior additions to its Field Sales Organization.Amy Radtke has joined us as a Director of IDN/ National Accounts. Amy has 14years of medical sales and national management experience with a track recordof success at Lumenis, Burwood Group, Inc., and Dräger Medical, Inc.Troy Knief has also joined us as a Director of IDN/National Accounts. In his13 years of medical sales, sales management and national account managementexperience he brings a track record of success at Baxter Healthcare/ApaTechDivision, Anulex Technologies, Synthes Spine, MedPointe Pharmaceuticals andForest Pharmaceuticals.Kevin M. O'Dare has joined us as Regional Vice President in our Pennsylvaniaand New England region. With over 14 years in the medical device field, hebrings a track record of success at Olympus Biotech (formerly StrykerBiotech), Ethicon-EndoSurgery and Osteotech, Inc.Robert Di Silvio, President explained, "We see an excellent opportunity forgrowth in Integrated Delivery Networks (IDNs), and the Federal Government,where the organizations can define and dictate product usage and caneffectively influence the end-user surgeon. For this reason, one leg ofBacterin's strategy is to add experienced selling resources with relationshipsin GPO/IDN and Federal Government immediately."